Efficacy of a Hemostatic Agent (PuraStat®) in Reducing Delayed Bleeding After Endoscopic Submucosal Dissection

Clinical trial NCT05031325 · UNKNOWN

Trial details

NCT number: NCT05031325
Sponsor: Mathieu Pioche
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Colo-rectal Cancer

Start date: 2022-02-28
Primary completion: 2022-02-28
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.